OncoTargets and Therapy
Volume 6, 2013 - Issue
Open access
101
Views
11
CrossRef citations to date
0
Altmetric
Review
Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management
Allen S Ho1 Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
, Sevin Turcan1 Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
& Timothy A Chan1 Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;2 Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY, USACorrespondence[email protected]
Pages 223-232
|
Published online: 21 Mar 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.